Christine Siu, CFO and Secretary at Eidos Therapeutics, Inc. (EIDX), sold 45,000 shares at $55.12 ($2.5M) on 2019-11-21, disclosed to the SEC on 2019-11-22.
Open-market sale of $2.5M EIDX by CFO and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.12 | 24,800 | $1.4M | 55.3% |
| 2 | $56.00 | 200 | $11K | 0.5% |
| 3 | $54.71 | 9,399 | $514K | 20.8% |
| 4 | $54.71 | 9,399 | $514K | 20.8% |
| 5 | $55.29 | 601 | $33K | 1.3% |
| 6 | $55.29 | 601 |
| $33K |
| 1.3% |
| Total | $54.96 avg | 45,000 | $2.5M | 100% |
| Filing → |
| EIDX | SELL | 2019-07-12 | $197K | — | Filing → |
| EIDX | SELL | 2019-06-07 | $1.0M | — | Filing → |
| EIDX | SELL | 2019-04-26 | $131K | — | Filing → |